TrialDiabetes, obesity & metabolism2014

Effect of the sodium glucose co-transporter 2 inhibitor canagliflozin on plasma volume in patients with type 2 diabetes mellitus.

S Sha et al.PubMed ↗Publisher ↗

No numbers read from the abstract.